Advertisement
UK markets open in 2 hours 43 minutes
  • NIKKEI 225

    38,409.97
    +857.81 (+2.28%)
     
  • HANG SENG

    17,110.21
    +281.28 (+1.67%)
     
  • CRUDE OIL

    83.44
    +0.08 (+0.10%)
     
  • GOLD FUTURES

    2,342.50
    +0.40 (+0.02%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • Bitcoin GBP

    53,530.50
    +54.03 (+0.10%)
     
  • CMC Crypto 200

    1,434.61
    +19.85 (+1.40%)
     
  • NASDAQ Composite

    15,696.64
    +245.33 (+1.59%)
     
  • UK FTSE All Share

    4,378.75
    +16.15 (+0.37%)
     

Decibel Therapeutics, Inc. (NASDAQ:DBTX) insider upped their holding by 63% earlier this year

Viewing insider transactions for Decibel Therapeutics, Inc.'s (NASDAQ:DBTX ) over the last year, we see that insiders were net buyers. This means that a larger number of shares were purchased by insiders in relation to shares sold.

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we would consider it foolish to ignore insider transactions altogether.

See our latest analysis for Decibel Therapeutics

Decibel Therapeutics Insider Transactions Over The Last Year

In the last twelve months, the biggest single purchase by an insider was when President Laurence Reid bought US$76k worth of shares at a price of US$7.64 per share. So it's clear an insider wanted to buy, even at a higher price than the current share price (being US$5.36). Their view may have changed since then, but at least it shows they felt optimistic at the time. In our view, the price an insider pays for shares is very important. It is encouraging to see an insider paid above the current price for shares, as it suggests they saw value, even at higher levels. Laurence Reid was the only individual insider to buy shares in the last twelve months.

ADVERTISEMENT

You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

insider-trading-volume
insider-trading-volume

Decibel Therapeutics is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Does Decibel Therapeutics Boast High Insider Ownership?

For a common shareholder, it is worth checking how many shares are held by company insiders. We usually like to see fairly high levels of insider ownership. Our information indicates that Decibel Therapeutics insiders own about US$693k worth of shares. This level of insider ownership is notably low, and not very encouraging.

What Might The Insider Transactions At Decibel Therapeutics Tell Us?

The fact that there have been no Decibel Therapeutics insider transactions recently certainly doesn't bother us. On a brighter note, the transactions over the last year are encouraging. We'd like to see bigger individual holdings. However, we don't see anything to make us think Decibel Therapeutics insiders are doubting the company. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Decibel Therapeutics. To that end, you should learn about the 4 warning signs we've spotted with Decibel Therapeutics (including 3 which are significant).

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here